Differences in the inhibitory effect of cimetidine on desipramine metabolism between rapid and slow debrisoquin hydroxylators

Clin Pharmacol Ther. 1987 Sep;42(3):278-82. doi: 10.1038/clpt.1987.147.

Abstract

The disposition of a 25 mg single oral dose of desipramine was investigated in five rapid and four slow hydroxylators of debrisoquin before and during oral administration of 1200 mg cimetidine daily. AUC and elimination half-life of desipramine increased during cimetidine administration in rapid but not in slow hydroxylators. This was the result of a decrease in overall clearance. The urinary recovery of 2-hydroxydesipramine was significantly decreased in rapid hydroxylators during cimetidine administration. We conclude that cimetidine inhibits the metabolism of desipramine in rapid but not in slow hydroxylators.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cimetidine / pharmacology*
  • Debrisoquin* / metabolism
  • Desipramine / blood
  • Desipramine / metabolism*
  • Half-Life
  • Humans
  • Hydroxylation
  • Isoquinolines*
  • Kinetics
  • Metabolic Clearance Rate

Substances

  • Isoquinolines
  • Cimetidine
  • Desipramine
  • Debrisoquin